India will allow the export of cough syrups only after samples are tested in a government laboratory, a government notice said on May 23, after Indian-made cough syrups were linked to the deaths of dozens of children in Uzbekistan and Gambia. Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice shared by the Health Ministry on May 23. Indian-made cough syrups were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year. To read the original story by Reuters, click here.
India Makes Tests Mandatory For Cough Syrup Export After Deaths In Uzbekistan, Gambia
Indian police at the gates of a branch of Marion Biotech, a health-care and pharmaceutical company whose cough syrup has been linked to the deaths of children in Uzbekistan. (file photo)